Selected highlights in the updated treatment of hypertension

Daniel Creegan; John W McEvoy

doi:10.1016/j.tcm.2023.11.001

Selected highlights in the updated treatment of hypertension

Trends Cardiovasc Med. 2023 Nov 21:S1050-1738(23)00097-X. doi: 10.1016/j.tcm.2023.11.001. Online ahead of print.

Authors

Daniel Creegan¹, John W McEvoy²

Affiliations

¹ University Hospital Galway and SAOLTA University Health Care Group, Galway, Ireland; School of Medicine, University of Galway, Ireland.
² University Hospital Galway and SAOLTA University Health Care Group, Galway, Ireland; School of Medicine, University of Galway, Ireland; National Institute for Prevention and Cardiovascular Health, Moyola Lane, Galway, H91 FF68, Ireland; Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: johnwilliam.mcevoy@universityofgalway.ie.

PMID: 37981201
DOI: 10.1016/j.tcm.2023.11.001

Abstract

Hypertension remains the leading international risk factor for cardiovascular disease and premature death but, despite effective treatments, hypertension remains significantly underdiagnosed and undertreated. In the present review paper, we provide a selected update on recent developments of interest in the management of hypertension. We focus on summarizing four topics that we believe are worth highlighting to a clinical audience: (1) the evidence and strong motivation for new lower systolic BP treatment targets; (2) new studies reporting on the efficacy of renal denervation in the management of hypertension; (3) interesting new data to inform the great salt debate; and (4), perhaps most importantly, pioneering new work highlighting the huge potential of multi-disciplinary care in the management of hypertension.

Keywords: Blood pressure; Hypertension; Review; Treatment; Update.

Publication types

Review